Literature DB >> 28102473

The Role of GluN2A in Cerebral Ischemia: Promoting Neuron Death and Survival in the Early Stage and Thereafter.

Yongjun Sun1,2, Xiaokun Cheng3, Jie Hu4, Zibin Gao5,6,7.   

Abstract

Over-activation of NMDA receptors is a crucial step required for brain damage following a stroke. Although clinical trials for NMDA receptor blockers have failed, the role of GluN2A subunit in cerebral ischemia has been extensively evaluated in recent years. However, the effect of GluN2A on neuron damage induced by cerebral ischemia remains a matter of controversy. The underlying reason may be that GluN2A mediates both pro-death and pro-survival effects. These two effects result from two mutually excluding pathways, Ca2+ overload-dependent pro-death signaling and C-terminal-dependent pro-survival signaling, respectively. During the early stage of cerebral ischemia, over-activation of GluN2A plays an important role in Ca2+ overload. Under this condition, pro-death signaling might overcome pro-survival signaling. When GluN2A activity is restored almost to the normal level over time, pro-survival signaling of GluN2A will be dominant. The hypothesis that GluN2A promotes neuron death and survival in the early stage of cerebral ischemia and thereafter will be introduced in detail in this review.

Entities:  

Keywords:  C-terminal signaling; Ca2+ overload; Cerebral ischemia; GluN2A

Mesh:

Substances:

Year:  2017        PMID: 28102473     DOI: 10.1007/s12035-017-0395-8

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  80 in total

Review 1.  MAPK cascade signalling and synaptic plasticity.

Authors:  Gareth M Thomas; Richard L Huganir
Journal:  Nat Rev Neurosci       Date:  2004-03       Impact factor: 34.870

2.  Coupling diverse routes of calcium entry to mitochondrial dysfunction and glutamate excitotoxicity.

Authors:  Ruslan I Stanika; Natalia B Pivovarova; Christine A Brantner; Charlotte A Watts; Christine A Winters; S Brian Andrews
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-29       Impact factor: 11.205

3.  Discovery of GluN2A-Selective NMDA Receptor Positive Allosteric Modulators (PAMs): Tuning Deactivation Kinetics via Structure-Based Design.

Authors:  Matthew Volgraf; Benjamin D Sellers; Yu Jiang; Guosheng Wu; Cuong Q Ly; Elisia Villemure; Richard M Pastor; Po-wai Yuen; Aijun Lu; Xifeng Luo; Mingcui Liu; Shun Zhang; Liang Sun; Yuhong Fu; Patrick J Lupardus; Heidi J A Wallweber; Bianca M Liederer; Gauri Deshmukh; Emile Plise; Suzanne Tay; Paul Reynen; James Herrington; Amy Gustafson; Yichin Liu; Akim Dirksen; Matthias G A Dietz; Yanzhou Liu; Tzu-Ming Wang; Jesse E Hanson; David Hackos; Kimberly Scearce-Levie; Jacob B Schwarz
Journal:  J Med Chem       Date:  2016-03-08       Impact factor: 7.446

4.  Involvement of the GluN2A and GluN2B subunits in synaptic and extrasynaptic N-methyl-D-aspartate receptor function and neuronal excitotoxicity.

Authors:  Xianju Zhou; Qi Ding; Zhuoyou Chen; Huifang Yun; Hongbing Wang
Journal:  J Biol Chem       Date:  2013-07-09       Impact factor: 5.157

5.  Elevation of p-NR2A(S1232) by Cdk5/p35 contributes to retinal ganglion cell apoptosis in a rat experimental glaucoma model.

Authors:  Jie Chen; Yanying Miao; Xiao-Han Wang; Zhongfeng Wang
Journal:  Neurobiol Dis       Date:  2011-04-30       Impact factor: 5.996

6.  Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95.

Authors:  Li Zhou; Fei Li; Hai-Bing Xu; Chun-Xia Luo; Hai-Yin Wu; Ming-Mei Zhu; Wei Lu; Xing Ji; Qi-Gang Zhou; Dong-Ya Zhu
Journal:  Nat Med       Date:  2010-11-21       Impact factor: 53.440

7.  Glutamate receptor-induced 45Ca2+ accumulation in cortical cell culture correlates with subsequent neuronal degeneration.

Authors:  D M Hartley; M C Kurth; L Bjerkness; J H Weiss; D W Choi
Journal:  J Neurosci       Date:  1993-05       Impact factor: 6.167

8.  Knockdown of m-calpain increases survival of primary hippocampal neurons following NMDA excitotoxicity.

Authors:  Matthew B Bevers; Eric Lawrence; Margaret Maronski; Neasa Starr; Michael Amesquita; Robert W Neumar
Journal:  J Neurochem       Date:  2009-01-22       Impact factor: 5.372

Review 9.  Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?

Authors:  Chrysanthy Ikonomidou; Lechoslaw Turski
Journal:  Lancet Neurol       Date:  2002-10       Impact factor: 44.182

Review 10.  Molecular Mechanism: ERK Signaling, Drug Addiction, and Behavioral Effects.

Authors:  Wei-Lun Sun; Pamela M Quizon; Jun Zhu
Journal:  Prog Mol Biol Transl Sci       Date:  2015-11-17       Impact factor: 3.622

View more
  4 in total

1.  Neuroprotection of Cytisine Against Cerebral Ischemia-Reperfusion Injury in Mice by Regulating NR2B-ERK/CREB Signal Pathway.

Authors:  Peng Zhao; Jia-Mei Yang; Yong-Sheng Wang; Yin-Ju Hao; Yu-Xiang Li; Nan Li; Jing Wang; Yang Niu; Tao Sun; Jian-Qiang Yu
Journal:  Neurochem Res       Date:  2018-06-15       Impact factor: 3.996

Review 2.  Progresses in GluN2A-containing NMDA Receptors and their Selective Regulators.

Authors:  Menghan Niu; Xin Yang; Yuanyuan Li; Yanping Sun; Long Wang; Jing Ha; Yinghua Xie; Zibin Gao; Changzheng Tian; Le Wang; Yongjun Sun
Journal:  Cell Mol Neurobiol       Date:  2022-01-03       Impact factor: 5.046

Review 3.  The Development of Novel Drug Treatments for Stroke Patients: A Review.

Authors:  Dmitry Frank; Alexander Zlotnik; Matthew Boyko; Benjamin Fredrick Gruenbaum
Journal:  Int J Mol Sci       Date:  2022-05-21       Impact factor: 6.208

4.  The Application of the Neuroprotective and Potential Antioxidant Effect of Ergotamine Mediated by Targeting N-Methyl-D-Aspartate Receptors.

Authors:  Shinhui Lee; Sanung Eom; Khoa V A Nguyen; Jiwon Lee; Youngseo Park; Hye Duck Yeom; Junho H Lee
Journal:  Antioxidants (Basel)       Date:  2022-07-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.